WallStSmart
ATHE

Alterity Therapeutics Ltd

NASDAQ: ATHE · HEALTHCARE · BIOTECHNOLOGY

$4.83
-2.52% today

Updated 2026-06-01

Market cap
$88.31M
P/E ratio
P/S ratio
13.31x
EPS (TTM)
$-0.60
Dividend yield
52W range
$3 – $7
Volume
0.0M

Alterity Therapeutics Ltd (ATHE) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$762486.00$507044.00$491997.00$428193.00$215008.00$156135.00$186664.00$150867.00$363775.00$176842.00$142657.00$132396.00$201174.00$108538.00$411567.00$4.34M$5.12M$3.92M$4.02M$5.44M
Revenue growth (YoY)-33.5%-3.0%-13.0%-49.8%-27.4%+19.6%-19.2%+141.1%-51.4%-19.3%-7.2%+51.9%-46.0%+279.2%+954.4%+18.1%-23.6%+2.6%+35.3%
Cost of revenue$399237.00$267880.00$-4.34M$-7.85M$257299.00$22810.00$21328.00$21799.00$29696.00$112427.00$360026.00$364665.00$285067.00$214304.00$127523.00
Gross profit$762486.00$507044.00$491997.00$428193.00$215008.00$-243102.00$186664.00$4.49M$8.21M$-80457.00$119847.00$111068.00$179375.00$78842.00$-112427.00$3.98M$4.76M$3.63M$3.80M$5.31M
Gross margin100.0%100.0%100.0%100.0%100.0%-155.7%100.0%2975.2%2256.7%-45.5%84.0%83.9%89.2%72.6%-27.3%91.7%92.9%92.7%94.7%97.7%
R&D$7.62M$4.49M$5.77M$2.22M$87992.00$2.33M$4.23M$7.95M$14.91M$12.30M$9.59M$5.70M$6.70M$12.98M$10.10M$12.28M$14.75M$13.20M$18.64M$14.40M
SG&A$4.31M$6.73M$6.30M$5.27M$3.92M$3.57M$506927.00$3.12M$3.09M$4.06M$3.59M$3.95M$4.32M$4.28M$3.33M$6.85M$5.43M$4.99M$4.77M$5.48M
Operating income$-11.41M$-10.99M$-12.73M$-8.29M$-4.90M$-6.28M$-5.32M$-7.80M$-12.55M$-10.44M$-8.59M$-6.88M$-7.77M$-12.71M$-10.41M$-15.18M$-15.50M$-14.64M$-19.60M$-14.57M
Operating margin-1496.9%-2167.6%-2588.2%-1935.7%-2279.4%-4020.2%-2849.3%-5171.4%-3450.6%-5901.1%-6019.2%-5197.9%-3862.5%-11713.7%-2530.3%-349.8%-302.6%-373.7%-487.7%-268.0%
EBITDA$-12.12M$-10.93M$-12.68M$-7.49M$-4.87M$-6.40M$-5.21M$-7.76M$-12.53M$-10.57M$-8.56M$-6.86M$-11.37M$-12.77M$-13.34M$-15.16M$-17.39M$-14.60M$-19.57M$-14.63M
EBITDA margin-1589.6%-2156.0%-2577.5%-1748.9%-2265.8%-4096.4%-2790.2%-5144.4%-3444.5%-5979.9%-6003.2%-5181.8%-5651.7%-11761.5%-3242.3%-349.3%-339.5%-372.8%-486.9%-269.0%
EBIT$-12.24M$-10.99M$-12.71M$-7.52M$-4.91M$-6.43M$-5.23M$-7.78M$-12.55M$-10.61M$-8.59M$-6.88M$-11.39M$-12.80M$-13.46M$-15.18M$-17.45M$-14.64M$-19.61M$-14.66M
Interest expense$0.00$0.00$0.00$0.00$0.00$3758.00$11544.00$17676.00$29978.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2504.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-11.73M$-11.14M$-13.59M$-7.52M$-4.91M$-6.43M$-5.24M$-7.79M$-13.33M$-5.89M$-7.73M$-7.54M$-8.27M$-11.96M$-10.06M$-15.31M$-12.85M$-13.81M$-19.12M$-12.15M
Net income growth (YoY)+5.0%-22.0%+44.6%+34.8%-31.1%+18.5%-48.6%-71.2%+55.8%-31.3%+2.4%-9.6%-44.7%+15.9%-52.2%+16.1%-7.5%-38.5%+36.5%
Profit margin-1537.9%-2197.0%-2762.2%-1756.9%-2282.2%-4119.0%-2806.9%-5161.7%-3664.1%-3327.9%-5418.3%-5696.6%-4108.8%-11020.8%-2444.2%-352.8%-250.7%-352.5%-475.8%-223.4%